Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Alexandar Tzankov"'
Autor:
Maria Martinez, Jan Dirks, Alexandar Tzankov, Dimitrios A. Tsakiris, Beatrice Drexler, Severin Baerlocher, Stefan Dirnhofer, Jakob Passweg
Publikováno v:
International Journal of Laboratory Hematology. 43:1078-1084
INTRODUCTION CD56 is aberrantly expressed in myeloid neoplasms including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Considering the adhesion effects of CD56, blast quantification in bone marrow might depend on the technique used
Autor:
Takayuki Murase, Satsuki Nakano, Tadashi Sakane, Hiromitsu Domen, Masako Chiyo, Satoshi Nagasaka, Michio Tanaka, Yutaka Kawahara, Masayuki Toishi, Takuji Tanaka, Shota Nakamura, Noriyoshi Sawabata, Jiro Okami, Hidenori Mukaida, Alexandar Tzankov, Malgorzata Szolkowska, Stefan Porubsky, Alexander Marx, Anja C. Roden, Hiroshi Inagaki
Publikováno v:
The American journal of surgical pathology. 46(8)
Thymic mucoepidermoid carcinoma (MEC) is a rare tumor, and its characteristics remain to be clarified. Here we investigated 20 cases of thymic MEC to systematically characterize its clinical, histopathologic, and molecular features. The median age of
Autor:
Katalin Kelemen, Rebecca L. King, Lisa M. Rimsza, Fiona E. Craig, Sa A. Wang, Kaaren K. Reichard, Hans-Peter Horny, Eric J. Duncavage, Tracy I. George, Leticia Quintanilla-Martinez, Attilio Orazi, Alexandar Tzankov
Publikováno v:
American Journal of Clinical Pathology. 155:239-266
Objectives The 2019 Workshop of the Society for Hematopathology/European Association for Haematopathology received and reviewed cases covering the spectrum of mastocytosis and related diseases, including morphologic mimics, focusing on recent updates
Autor:
Enrico Iurlaro, Andrés Antón, Alexandar Tzankov, Matthias S. Matter, Lidia Alonso, Enrico Ferrazzi, Carlota Rubio-Perez, Giovanna Lunghi, Paolo Nuciforo, Roberta Erra, Sara Simonetti, Anna Maria Fagnani, Maria Piñana, Stefano Ferrero, Joan Seoane, Andrea Ronchi, Fulvia Milena Cribiù, Luigi Terracciano, Carlo Pietrasanta, Garazi Serna, Lorenza Pugni, Giorgio Alberto Croci
Publikováno v:
J Clin Invest
The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the pathophysiology of the placenta and its impact on pregnancy outcome has not yet been fully elucidated. Here, we present a comprehensive clinical, morphologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a3f3fc4cdddabd828d9b84db41cd14
https://europepmc.org/articles/PMC7954587/
https://europepmc.org/articles/PMC7954587/
Autor:
Michael Grau, Kirsty Wienand, Pia Veratti, Gustavo Tapia, Tabea Erdmann, Eva González-Barca, Falko Fend, Jan-Niklas Heming, Björn Chapuy, Irina Bonzheim, Sophia Ehrenfeld, Alexandar Tzankov, Javier Menárguez, Mathias Lutz, Philip Sander, Matthew R. Wilson, José-Tomás Navarro, Julia Richter, Wolfram Klapper, Stefan Dirnhofer, Cornelius Miething, Pau Abrisqueta, Andreas Rosenwald, Fina Climent, Ioannis Anagnostopoulos, Mario Lamping, Wendan Xu, Annette M. Staiger, Georg Lenz, Myroslav Zapukhlyak, Philipp Berning, Vanessa Borgmann, Wolfgang Hartmann, Peter Lenz, Teresa Aldamiz, Fabian Frontzek, German Ott, Maria Joao Baptista, Josep Castellví, Antonio Salar, Jose Luis Mate, Heike Horn, John R. Goodlad, Ramona Wullenkord
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Nature Communications
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientia
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Universidad de Barcelona
Nature Communications
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientia
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Plasmablastic lymphoma (PBL) represents a rare and aggressive lymphoma subtype frequently associated with immunosuppression. Clinically, patients with PBL are characterized by poor outcome. The current understanding of the molecular pathogenesis is l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd88233e6b47877ca5d45e25f3a08e7
http://hdl.handle.net/2445/180256
http://hdl.handle.net/2445/180256
Autor:
Michael Sprung, Mark Kuehnel, Markus Osterhoff, Jasper Frohn, Danny Jonigk, Fabian Westermeier, Marius Reichardt, Alexandar Tzankov, Christopher Werlein, Marina Eckermann, Tim Salditt
Publikováno v:
eLife 9, e60408 (1-25) (2020). doi:10.7554/eLife.60408
eLife, Vol 9 (2020)
eLife
eLife, Vol 9 (2020)
eLife
We present a three-dimensional (3D) approach for virtual histology and histopathology based on multi-scale phase contrast x-ray tomography, and use this to investigate the parenchymal architecture of unstained lung tissue from patients who succumbed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f603b8225256bc030678e189a6d4ade
https://bib-pubdb1.desy.de/record/454543
https://bib-pubdb1.desy.de/record/454543
Autor:
Alexandar Tzankov, Christoph Bucher, Benjamin Bodenmann, Martina Kleber, Sarah Kraft, Dimitrios A. Tsakiris, Jakob Passweg, Noémie Bollinger, Dominik Heim, Claudia Lengerke, Michael Medinger
Publikováno v:
Bone Marrow Transplantation. 54:540-548
Transplant-associated thrombotic microangiopathy (TA-TMA) remains a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). We hypothesized that TA-TMA correlates with steroid-refractory acute graft-vs.-host disease (aGv
Autor:
Roger von Moos, Michael Stumm, Vincent Prêtre, Cinta Hierro, Alexandar Tzankov, Vincent Bize, Sasa Dimitrijevic, Viviane Hess, Cristiana Sessa, Reto Ritschard, Jordi Rodon, Richard Herrmann, Alexa Childs, Vladimir Cmiljanovic, Simona Berardi, Rebecca Kristeleit, Nicholas F. Brown, Markus Joerger, Andreas Wicki, A. Xyrafas, Hanne Hawle, D. Hess, Natasa Cmiljanovic
Publikováno v:
European Journal of Cancer. 96:6-16
Background PQR309 is an orally bioavailable, balanced pan-phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR) C1 and mTORC2 inhibitor. Patients and methods This is an accelerated titration, 3 + 3 dose-escalation, open-label pha
Autor:
Anne Graber, Alexandar Tzankov, Peter Meyer, Gieri Cathomas, Stefan Dirnhofer, Magdalena M. Gerlach, Visar Vela, Darius Juskevicius
Publikováno v:
Hematological oncologyREFERENCES. 38(3)
The majority of ocular adnexal (OA) lymphomas (OAL) are extranodal marginal zone lymphomas (MZL). First high throughput sequencing (HTS) studies on OA-MZL showed inconsistent results and the distribution of mutations in reactive lymphoid lesions of t
Autor:
M. Ponzoni, Wayne Tam, J.H.J.M. van Krieken, Lijuan Deng, Praveen Jain, Luis Fayad, Jianxiang Wang, Govind Bhagat, Ganiraju C. Manyam, Hagop M. Kantarjian, L. J. Medeiros, Y Liu, Ken H. Young, Karen Dybkær, Jorge E. Cortes, C. Visco, Yong Li, Jane N. Winter, Zhilei Yao, Robert Z. Orlowski, Anna Ferreri, Alexandar Tzankov, Zijun Y. Xu-Monette, M A Piris, Eric D. Hsi, Yongping Song, Michael Boe Møller
Publikováno v:
Leukemia, 32, 353-363
Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkaer, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353-363 . https://doi.org/10.1038/leu.2017.222
Leukemia, 32, 2, pp. 353-363
Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkær, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353–363 . https://doi.org/10.1038/leu.2017.222
Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkaer, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353-363 . https://doi.org/10.1038/leu.2017.222
Leukemia, 32, 2, pp. 353-363
Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkær, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353–363 . https://doi.org/10.1038/leu.2017.222
In diffuse large B-cell lymphoma (DLBCL), the clinical and biological significance of concordant and discordant bone marrow (BM) involvement have not been well investigated. We evaluated 712 de novo DLBCL patients with front-line rituximab-containing